SEC Form 4 · accession 0001131096-16-000405
ATHENAHEALTH INC · ATHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Kane
Director
Period of report
Apr 27, 2016
Accepted (ET)
Oct 31, 2016 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131096
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 27, 2016 | M | 2,875 | $15.27 | A | 10,708 | D | |
| Common StockF3,F1 | Apr 27, 2016 | S | 1,251 | $140.48 | D | 9,457 | D | |
| Common StockF4,F1 | Apr 27, 2016 | S | 1,224 | $141.30 | D | 8,233 | D | |
| Common StockF5,F1 | Apr 27, 2016 | S | 400 | $142.18 | D | 7,833 | D | |
| Common Stock | Oct 27, 2016 | M | 2,875 | $15.27 | A | 10,708 | D | |
| Common StockF6 | Oct 27, 2016 | S | 1,500 | $103.48 | D | 9,208 | D | |
| Common StockF7 | Oct 27, 2016 | S | 1,320 | $104.95 | D | 7,888 | D | |
| Common Stock | Oct 27, 2016 | S | 55 | $105.77 | D | 7,833 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $15.27 | Apr 27, 2016 | M | 2,875 | D | Jul 26, 2007 | Jul 26, 2017 | Common Stock | 2,875 | 4,000 | D |
| Stock Option (Right to Buy) | $15.27 | Oct 27, 2016 | M | 2,875 | D | Jul 26, 2007 | Jul 26, 2017 | Common Stock | 2,875 | 1,125 | D |
Explanation of responses
- F1Reflects securities held as of April 27, 2016 and does not take into account transactions occurring on July 27, 2016, as timely reported by the Reporting Person on July 28, 2016.
- F2The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on February 25, 2015, in accordance with Rule 10b5-1.
- F3Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.98, inclusive.
- F4Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.01 to $141.90, inclusive.
- F5Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.05 to $142.27, inclusive.
- F6Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.17 to $103.80, inclusive.
- F7Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.59 to $105.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) - (7) to this Form 4.